Covered recipient · General Payments record
KIMI KAY GUFFEY
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Primary Care
General Payments · PY2022–2024
$691.96
- Reported across 19 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $543.33 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $185.83 | 5 |
| ABBVIE INC. | $165.80 | 6 |
| Lilly USA, LLC | $140.26 | 2 |
| PFIZER INC. | $23.56 | 1 |
| Insulet Corporation | $14.23 | 1 |
| Novo Nordisk AS | $13.65 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $7.35 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107262487 | CMS |
| ABBVIE INC. | $8.57 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107262489 | CMS |
| ABBVIE INC. | $17.97 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107262491 | CMS |
| ABBVIE INC. | $118.98 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107262493 | CMS |
| ABBVIE INC. | $5.15 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107262495 | CMS |
| ABBVIE INC. | $7.78 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107262497 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.01 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104609852 | CMS |
| AstraZeneca Pharmaceuticals LP | $123.32 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104567722 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.28 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104711613 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.67 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105370284 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.55 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104574402 | CMS |
| Insulet Corporation | $14.23 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116821620 | CMS |
| Lilly USA, LLC | $15.26 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135773118 | CMS |
| Lilly USA, LLC | $125.00 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135774770 | CMS |
| Novo Nordisk Inc | $13.65 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100301393 | CMS |
| PFIZER INC. | $23.56 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131256334 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.